BioSpace News Archive

Genethon Using Artificial Intelligence to Improve Effectiveness of Gene Therapies and Patient Access

Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association, provided an update on its efforts to employ Artificial Intelligence in revolutionizing the development and bioproduction of gene therapies.

November 27, 2023
·
2 min read
Biotech Beach

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Turnstone Biologics Corp. today announced that Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer, will participate in the Piper Sandler 35th Annual Healthcare Conference taking place November 28-30, 2023 in New York.

November 27, 2023
·
1 min read
Lone Star Bio

TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023

TFF Pharmaceuticals, Inc. today announced that company management will be participating in the 2023 Benchmark Discovery One-on-One Investor Conference being held December 7, 2023 at the New York Athletic Club in New York City.

November 27, 2023
·
4 min read
Deals

Arvinas Announces Oversubscribed $350 Million Private Placement

Arvinas, Inc. today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors to sell 12,963,542 shares of common stock at a price of $21.36 per share.

November 27, 2023
·
6 min read
FDA

Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer

Genelux Corporation today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer.

November 27, 2023
·
3 min read
FDA

RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034

RedHill Biopharma Ltd. (NASDAQ: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced that the U.S. FDA (U.S. Food and Drug Administration) has granted five years’ market exclusivity for Talicia.

November 27, 2023
·
12 min read
Biotech Bay

Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy

Alterity Therapeutics today announced a poster presentation from the Company’s Biomarkers of progression in Multiple System Atrophy (bioMUSE) Natural History Study at the recent 34th International Symposium on the Autonomic Nervous System (AAS).

November 27, 2023
·
7 min read
FDA

Genmab Announces Positive Regulatory Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma

Genmab Announces Positive Regulatory Updates for Epcoritamab (EPKINLY ® /TEPKINLY ® ) for the Treatment of Relapsed/Refractory Follicular Lymphoma.

November 27, 2023
·
14 min read
Pharm Country

TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ET

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 6th Annual Evercore ISI HealthCONx Conference, being held at the Kimpton EPIC Hotel, in Miami, Florida on November 28 - 30, 2023.

November 27, 2023
·
1 min read
BioMidwest

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23

Royal Philips, a global leader in health technology, placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite and Affiniti at #RSNA23.

November 27, 2023
·
4 min read